Free Trial

BioSyent (RX) Insider Trading & Ownership

BioSyent logo
C$11.64 -0.11 (-0.94%)
(As of 05:28 PM ET)

BioSyent (CVE:RX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
33.65%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
C$52,327.95
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
C$7.74 M
Get RX Insider Trade Alerts

Want to know when executives and insiders are buying or selling BioSyent stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

RX Insider Buying and Selling by Quarter

BioSyent Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/16/2024Seyed Ahmad AshrafiDirectorSell532C$12.02C$6,394.64
12/12/2024Robert Joseph MarchSenior OfficerSell4,775C$11.65C$55,628.75
11/25/2024Peter Douglas LockhardDirectorSell637C$11.45C$7,293.65
11/22/2024FAX Capital Corp.InsiderSell230,800C$11.12C$2,566,496.00
9/23/2024Peter Douglas LockhardDirectorSell600C$11.10C$6,660.00
9/20/2024Seyed Ahmad AshrafiDirectorSell2,320C$10.95C$25,404.00
7/23/2024FAX Capital Corp.InsiderSell500,000C$10.05C$5,025,000.00
6/28/2024Sharan RaghubirSenior OfficerSell423C$10.04C$4,246.92
6/20/2024Sharan RaghubirSenior OfficerSell1,755C$10.01C$17,566.50
6/12/2024Rene GoehrumDirectorSell1,522C$9.38C$14,276.36
5/22/2024Peter Douglas LockhardDirectorSell432C$8.95C$3,866.40
4/29/2024BioSyent Inc.InsiderBuy5,100C$8.55C$43,627.95
3/28/2024Larry AndrewsDirectorBuy1,000C$8.70C$8,700.00
3/26/2024Peter Douglas LockhardDirectorSell600C$8.70C$5,220.00
(Data available from 1/1/2013 forward)

RX Insider Trading Activity - Frequently Asked Questions

The list of insiders at BioSyent includes BioSyent Inc., Blair Driscoll, FAX Capital Corp., Larry Andrews, Peter Douglas Lockhard, Rene Goehrum, Robert Joseph March, Seyed Ahmad Ashrafi, and Sharan Raghubir. Learn more on insiders at RX.

33.65% of BioSyent stock is owned by insiders. Learn more on RX's insider holdings.

The following insiders have purchased RX shares in the last 24 months: BioSyent Inc. (C$43,627.95), and Larry Andrews (C$8,700.00).

Insiders have purchased a total of 6,100 RX shares in the last 24 months for a total of C$52,327.95 bought.

The following insiders have sold RX shares in the last 24 months: FAX Capital Corp. (C$8,091,996.00), Peter Douglas Lockhard (C$23,040.05), Rene Goehrum (C$14,276.36), Robert Joseph March (C$55,628.75), Seyed Ahmad Ashrafi (C$40,298.64), and Sharan Raghubir (C$21,813.42).

Insiders have sold a total of 810,396 BioSyent shares in the last 24 months for a total of C$8,247,053.22 sold.

BioSyent Key Executives

  • Mr. René C. Goehrum (Age 65)
    Chairman, CEO & President
    Compensation: $594.99k
  • Mr. Robert J. March
    VP of Finance & CFO
  • Mr. Joost van der Mark
    Vice President of Corporate Development
  • Ms. Neelu Atwal
    Director of Human Resources


This page (CVE:RX) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners